Bluejay Diagnostics (BJDX) Return on Capital Employed Growth (3y) (2024 - 2026)
Bluejay Diagnostics (BJDX) Return on Capital Employed Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | - |
| 10 | Bluejay Diagnostics | 1.05 Mn | 1.05 Mn | - | -4,955.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,955.00 |
| Dec 31, 2025 | -7,049.00 |
| Sep 30, 2025 | -10,148.00 |
| Jun 30, 2025 | -10,474.00 |
| Mar 31, 2025 | -11,623.00 |
| Dec 31, 2024 | -7,944.00 |